Bayer AG (BAYRY)
-OTC Markets 108.65 
0.05(0.05%) 10:18AM EDT
| Prev Close: | 108.70 |
|---|
| Open: | 108.63 |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 140.24 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 108.63 - 109.26 |
|---|
| 52wk Range: | 59.57 - 110.66 |
|---|
| Volume: | 1,879 |
|---|
| Avg Vol (3m): | 38,743 |
|---|
| Market Cap: | 89.85B |
|---|
| P/E (ttm): | 27.06 |
|---|
| EPS (ttm): | 4.01 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Zacks Bull and Bear of the Day Highlights: Mohawk Industries, Aruba Networks, Bayer, United Therapeutics and ActelionZacks(Fri 7:57AM EDT)
- Positive Data on Bayer CandidateZacks(Thu, May 23)
- Bayer Files Riociguat in JapanZacks(Tue, May 21)
- Yet Another Acquisition for BayerZacks(Tue, May 21)
- Bayer's Xofigo Cleared in the USZacks(Thu, May 16)
- Zacks Industry Outlook Highlights: Life Technologies, Thermo Fisher Scientific, Bayer, Conceptus and Becton, Dickinson and Co.Zacks(Thu, May 16)
- Hospital to probe East German medical trialsAP(Mon, May 13)
- A Strategic Healthcare Deal With an Expensive Price Tagat Motley Fool(Wed, May 8)
- The Zacks Analyst Blog Highlights: Bayer, Biogen Idec, Conceptus, Microsoft and J. C. PenneyZacks(Tue, May 7)
- Bayer Discontinues Hemophilia StudyZacks(Mon, May 6)
- Regeneron Earnings Soar As Eylea Sales SkyrocketInvestor's Business Daily(Fri, May 3)
- Why AVEO Pharmaceuticals Shares Were Evisceratedat Motley Fool(Thu, May 2)
- BAYER AKTIENGESELLSCHAFT FinancialsEDGAR Online Financials(Thu, May 2)
- Bayer Aims to Expand HealthCare PortfolioZacks(Tue, Apr 30)
- Dow, S&P 500 Approach Highs; Health Care Names Shine Againat Investor's Business Daily(Mon, Apr 29)
Key Statistics
| Forward P/E (1 yr): | 14.94 |
|---|
| P/S (ttm): | 1.74 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 6.54 |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | 1.0 |
|---|
| PEG Ratio (5 yr expected): | 1.74 |
|---|
Business Summary
Bayer Aktiengesellschaft develops, produces, and markets health care and agriculture products, and high-tech materials worldwide. The companys HealthCare segment provides pharmaceuticals, such as prescription pharmaceuticals for the treatmen...
View More